| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9027563 | Thérapie | 2005 | 7 Pages |
Abstract
Creatinine clearance, phosphataemia, proteinuria and glycosuria should be closely monitored in patients receiving tenofovir therapy.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Pierre Lochet, Helène Peyrière, Vincent Le Moing, Jean-Pierre Blayac, Sylvie Hansel, Jacques Reynes,